BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)
Clinical trial NCT03576378 · UNKNOWN
Trial details
- NCT number
- NCT03576378
- Sponsor
- Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-08
- Primary completion
- 2023-10-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.